BTIG Reiterates Buy Rating on Mobia Medical, Keeps $19 Target
BTIG reiterated its Buy rating and $19 price target on Mobia Medical. The target implies 115.7% upside from the Oct. 19 close of $8.81.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.